Kathleen E. Corey

14.1k total citations · 5 hit papers
167 papers, 7.0k citations indexed

About

Kathleen E. Corey is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kathleen E. Corey has authored 167 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Epidemiology, 82 papers in Hepatology and 32 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kathleen E. Corey's work include Liver Disease Diagnosis and Treatment (133 papers), Liver Disease and Transplantation (39 papers) and Hepatitis C virus research (35 papers). Kathleen E. Corey is often cited by papers focused on Liver Disease Diagnosis and Treatment (133 papers), Liver Disease and Transplantation (39 papers) and Hepatitis C virus research (35 papers). Kathleen E. Corey collaborates with scholars based in United States, United Kingdom and South Korea. Kathleen E. Corey's co-authors include Raymond T. Chung, Giovanni Targher, Christopher D. Byrne, Tracey G. Simon, Michael Roden, Hui Zheng, Zobair M. Younossi, Joseph K. Lim, Joseph Misdraji and Lee M. Kaplan and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and JAMA.

In The Last Decade

Kathleen E. Corey

163 papers receiving 6.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments

2021 553 citations Giovanni Targher, Kathleen E. Corey et al. profile →
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis

2021 379 citations Kathleen E. Corey, Tracey G. Simon et al. profile →
AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review

2020 332 citations Zobair M. Younossi, Kathleen E. Corey et al. Gastroenterology profile →
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis

2016 313 citations Xiaobo Wang, Ze Zheng et al. Cell Metabolism profile →
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis

2024 48 citations Tracey G. Simon, Kathleen E. Corey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen E. Corey United States	44	4.8k	2.5k	1.9k	1.3k	962	167	7.0k
Yuichiro Eguchi Japan	40	4.8k 1.0×	3.0k 1.2×	1.6k 0.9×	1.0k 0.8×	981 1.0×	178	6.7k
Laura Wilson United States	34	4.9k 1.0×	1.9k 0.8×	2.0k 1.1×	1.0k 0.8×	744 0.8×	105	6.4k
Pegah Golabi United States	37	6.2k 1.3×	2.9k 1.2×	2.6k 1.4×	1.0k 0.8×	975 1.0×	106	7.5k
James M. Paik United States	34	5.5k 1.2×	2.3k 0.9×	2.5k 1.3×	877 0.7×	778 0.8×	84	6.4k
Mazen Noureddin United States	49	7.1k 1.5×	3.9k 1.6×	2.7k 1.4×	1.3k 1.0×	1.3k 1.3×	272	9.1k
Jörn M. Schattenberg Germany	50	6.7k 1.4×	3.4k 1.4×	2.5k 1.3×	1.5k 1.1×	1.6k 1.7×	332	9.2k
Sven Francque Belgium	48	7.3k 1.5×	3.2k 1.3×	2.9k 1.5×	1.5k 1.1×	1.5k 1.5×	194	9.1k
Nahúm Méndez‐Sánchez Mexico	43	4.2k 0.9×	2.4k 1.0×	1.3k 0.7×	2.0k 1.5×	1.1k 1.2×	302	7.8k
Mohammad Shadab Siddiqui United States	37	4.8k 1.0×	2.8k 1.1×	1.6k 0.8×	1.3k 1.0×	718 0.7×	151	6.1k
Antonio Grieco Italy	38	3.9k 0.8×	2.1k 0.8×	1.4k 0.7×	1.0k 0.8×	1.5k 1.6×	225	6.5k

Countries citing papers authored by Kathleen E. Corey

Since Specialization

Citations

This map shows the geographic impact of Kathleen E. Corey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen E. Corey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen E. Corey more than expected).

Fields of papers citing papers by Kathleen E. Corey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen E. Corey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen E. Corey. The network helps show where Kathleen E. Corey may publish in the future.

Co-authorship network of co-authors of Kathleen E. Corey

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen E. Corey. A scholar is included among the top collaborators of Kathleen E. Corey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen E. Corey. Kathleen E. Corey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corey, Kathleen E., et al.. (2025). Liver fibrosis is associated with clinical and economic burden of cardiovascular disease in MASH. JHEP Reports. 8(1). 101621–101621.

Wong, Lai Ping, Pinzhu Huang, Charlotte Costentin, et al.. (2025). Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis. Nature Immunology. 26(9). 1596–1611. 2 indexed citations

Gawrieh, Samer, Jordan E. Lake, Mark Tann, et al.. (2023). Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study. Hepatology. 78(2). 578–591. 20 indexed citations

Haas, Mary E., James P. Pirruccello, Sam Friedman, et al.. (2021). Machine learning enables new insights into genetic contributions to liver fat accumulation. Cell Genomics. 1(3). 100066–100066. 55 indexed citations

Kim, Mi Na, Chun‐Han Lo, Kathleen E. Corey, et al.. (2021). Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis. Clinical Nutrition. 41(2). 356–364. 34 indexed citations

Corey, Kathleen E., Rebecca Pitts, Michelle Lai, et al.. (2021). ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD. Journal of Hepatology. 76(1). 25–33. 48 indexed citations

Wang, Xiaobo, Hongxue Shi, Changyu Zhu, et al.. (2021). TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. Journal of Hepatology. 76(4). 910–920. 32 indexed citations

Stanley, Takara L., Lindsay T. Fourman, Isabel Zheng, et al.. (2020). Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism. 106(2). e520–e533. 76 indexed citations

Osganian, Stephanie A., et al.. (2020). Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis. Gastroenterology. 159(6). 2232–2234.e4. 16 indexed citations

10.

Younossi, Zobair M., Kathleen E. Corey, Naim Alkhouri, et al.. (2020). Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices. Alimentary Pharmacology & Therapeutics. 52(3). 513–526. 62 indexed citations

11.

Long, Michelle T., Xiaoyu Zhang, Hanfei Xu, et al.. (2020). Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology. 73(2). 548–559. 77 indexed citations

12.

Verna, Elizabeth C., Marina Serper, Jaime Chu, et al.. (2020). Clinical Research in Hepatology in the COVID‐19 Pandemic and Post‐Pandemic Era: Challenges and the Need for Innovation. Hepatology. 72(5). 1819–1837. 16 indexed citations

13.

Sim, Jae-Hun, Takara L. Stanley, Kathleen E. Corey, et al.. (2020). Pro-Inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection. AIDS Research and Human Retroviruses. 37(5). 385–390. 10 indexed citations

14.

Targher, Giovanni, Kathleen E. Corey, & Christopher D. Byrne. (2020). NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment. Diabetes & Metabolism. 47(2). 101215–101215. 114 indexed citations

15.

Danford, Christopher J., Jennifer Y. Lee, Ian A. Strohbehn, Kathleen E. Corey, & Michelle Lai. (2020). Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record. Digestive Diseases and Sciences. 66(5). 1452–1460. 6 indexed citations

16.

Cai, Bishuang, Paola Dongiovanni, Kathleen E. Corey, et al.. (2019). Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. Cell Metabolism. 31(2). 406–421.e7. 192 indexed citations

17.

Osganian, Stephanie A., et al.. (2015). Lipid and Lipoprotein Metabolism in Liver Disease. 22 indexed citations

18.

Corey, Kathleen E., Joseph Misdraji, Lindsay Y. King, et al.. (2015). Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology. Digestive Diseases and Sciences. 60(8). 2523–2528. 40 indexed citations

19.

Mueller, Jessica L., Lindsay Y. King, Tian Gao, et al.. (2014). Poster Session 1: Viral Hepatitis and Liver Transplant. Hepatology. 60. 532A–545A.

20.

Corey, Kathleen E., Erin M. Kane, Craig A. Munroe, et al.. (2009). Hepatitis C Virus Infection and Its Clearance Alter Circulating Lipids. Hepatology. 50(4). 1030–1037. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact